mazindol has been researched along with Froehlich's Syndrome in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Usami, M | 1 |
| Seino, Y | 1 |
| Nishi, S | 1 |
| Nakahara, H | 1 |
| Ikeda, M | 1 |
| Matsukura, S | 1 |
| Imura, H | 1 |
1 other study available for mazindol and Froehlich's Syndrome
| Article | Year |
|---|---|
[Effect of mazindol on insulin and glucagon secretion in ventromedial hypothalamic obese rats].
Topics: Animals; Body Weight; Female; Glucagon; Hypothalamic Diseases; Indoles; Insulin; Insulin Secretion; | 1985 |